149707-75-5

Basic information

• Product Name: 2,3,4,6-Tetra-O-benzoyl-1-O-(2,2,2-trichloroethanimidoyl)-α-D-glucopyranose
• Synonyms: 2,3,4,6-Tetra-O-benzoyl-1-O-(2,2,2-trichloroethanimidoyl)-α-D-glucopyranose;alpha-D-Glucopyranose 2,3,4,6-tetrabenzoate 1-(2,2,2-trichloroethanimidate)
• CAS NO: 149707-75-5
• Molecular Weight: 740.978
• EINECS: -0
• Mol File: 149707-75-5.mol
• Article Data: 32

Chemical Properties

• CAS DataBase Reference: 2,3,4,6-Tetra-O-benzoyl-1-O-(2,2,2-trichloroethanimidoyl)-α-D-glucopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4,6-Tetra-O-benzoyl-1-O-(2,2,2-trichloroethanimidoyl)-α-D-glucopyranose(149707-75-5)
• EPA Substance Registry System: 2,3,4,6-Tetra-O-benzoyl-1-O-(2,2,2-trichloroethanimidoyl)-α-D-glucopyranose(149707-75-5)

Safety Data

• Hazardous Substances Data: 149707-75-5(Hazardous Substances Data)

Usage

Molecular weight

623.9

Structure

A glucose ring with benzoyl groups attached to the 2, 3, 4, and 6 positions, and a 2,2,2-trichloroethanimidoyl group attached to the 1 position.

Use

As a protecting group for the hydroxyl (OH) groups of glucose in organic chemistry.

Function

Allows for selective removal of protecting groups under specific reaction conditions, and controls the regioselectivity of reactions to prevent unwanted side reactions.

Application

Commonly used in the synthesis of complex carbohydrates and natural products.

Upstream product

• 627466-84-6 2,3,4,6-tetra-O-benzoyl-D-galactose 
• 545-06-2 trichloroacetonitrile 
• 7464-56-4 1-O-allyl-α-D-glucopyranoside 
• 1435780-53-2 allyl 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranoside 
• 492-61-5 β-D-glucose 
• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-β-D-glucopyranose 
• 97590-76-6 benzyl-O-β-D-glucopyranoside 
• 18685-18-2 3-O-benzyl-1,2-5,6-O-diisopropylidene-α-D-glucofuranose 
• 100-44-7 benzyl chloride 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 64768-20-3 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranose 
• 22415-91-4 1,2,3,4,6-penta-O-benzoyl-α-D-glucopyranose 
• 492-62-6 alpha-D-glucopyranose 
• 98-88-4 benzoyl chloride 

Downstream Products

• 192126-03-7 C₄₉H₅₈O₁₄SSi 
• 233674-88-9 2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl-(1->4)-1,2,3,6-tetra-O-benzoyl-α-D-mannopyranose 
• 233675-54-2 2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl-(1->4)-1,2,3,6-tetra-O-benzoyl-α-D-mannopyranose 
• 3391-81-9 androseptoside A 
• 7073-61-2 cholesteryl β-D-glucopyranoside 
• 14144-06-0 trillin 
• 287203-80-9 Ethyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1->4)-2,3-O-isopropylidene-1-thio-α-L-rhamnopyranoside 
• 291774-79-3 methyl 2,3-di-O-acetyl-6-phenylthio-6-deoxy-4-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-α-D-glucopyranoside 
• 324740-36-5 C₇₇H₈₆O₁₃Si 
• 475203-56-6 phenyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→3)-[2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→6)]-2,4-di-O-acetyl-1-thio-β-D-glucopyranoside 
• 908835-51-8 C₈₆H₉₇NO₁₇ 

Relevant articles and documents

VACCINE COMPOSITIONS AND ANTIBODIES FOR LYME DISEASE

The present invention relates to vaccine compositions comprising lipid antigens, antibodies targeting lipid antigens, pharmaceutical compositions comprising such and their use in diagnosing, monitoring, treating, and preventing infectious disease, such as Lyme disease. In one aspect, administered is a therapeutically effective amount of a vaccine composition comprising a lipid antigen, an antibody or fragment thereof binding a lipid antigen, and/or a pharmaceutical composition comprising an antibody or fragment thereof binding a lipid antigen. Other aspects are described.

Delta-oleanolic acid saponin compound and medical application thereof

The invention discloses a delta-oleanolic acid saponin compound and medical application thereof. The delta-oleanolic acid saponin compound is a compound with a structural formula shown as a formula (I), and pharmaceutically acceptable salt or ester or pro

Aralia saponin derivative as well as preparation method and application thereof (by machine translation)

The invention discloses an Aralia saponin derivative as well as a preparation method and application, thereof. A structure represented by the general formula (I). To the invention, oleanolic acid and four sugar, coffee acid or 3 - methoxy 4 - hydroxycinna